Evaluation of the PROPEL® mini sinus implant for the treatment of frontal sinus disease-Reference-Cited by-同舟云学术

Evaluation of the PROPEL® mini sinus implant for the treatment of frontal sinus disease

Published:2016-11-06 Issue:12 Volume:13 Page:1789-1793
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Santarelli Griffin D.¹,Han Joseph K.¹

Affiliation:

1. Department of Otolaryngology and Head & Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1250740

Reference20 articles.

1. Propel Sinus Stent. Instructions for usage, Intersect ENT; 2016. Intersect ENT. Available from: http://propelopens.com/the-propel-advantage/clinical-data

2. Intersect ENT. Intersect ENT announces FDA approval of new steroid-releasing implant, allowing more chronic sinusitis patients to benefit from localized drug delivery; 2012. Available from: http://propelopens.com/wp-content/uploads/2014/04/IntersectENT_PressRelease-PROPEL_mini_FDA_Approval_2012_11_06.pdf

3. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening

4. Mometasone Furoate

5. Advance II

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Pre-Operative Estimation of Draf III Expected Diameter on Surgical Outcome;Journal of Personalized Medicine;2024-09-09

2. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study;Current Medical Research and Opinion;2023-04-06

3. Biomechanical characteristics of self-expanding sinus stents during crimping and deployment_A comparison between different biomaterials;Journal of the Mechanical Behavior of Biomedical Materials;2023-02

4. Short‐term postoperative efficacy of steroid‐eluting stents for eosinophilic chronic rhinosinusitis with nasal polyps: A randomized clinical trial;International Forum of Allergy & Rhinology;2022-09-26

5. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities;Expert Opinion on Drug Delivery;2022-08-02